|
|
Men+Tdap+HPV |
Placebo+Tdap+HPV |
Total |
| |
n=402 |
n=399 |
N=801 |
| Age (Yrs) |
11.9 ± 1.7 |
11.8 ± 1.5 |
11.9 ± 1.6 |
| Sex |
|
|
|
| Male |
233 (58%) |
244 (61%) |
477 (60%) |
| Female |
169 (42%) |
155 (39%) |
324 (40%) |
| Race |
|
|
|
| Asian |
5 (1%) |
7 (2%) |
12 (1%) |
| Black, Non-Hispanic |
39 (10%) |
36 (9%) |
75 (9%) |
| White, Non-Hispanic |
319 (79%) |
310 (78%) |
629 (79%) |
| Native American/Alaskan |
1 (<1%) |
2 (<1%) |
3 (<1%) |
| Pacific/Hawaii |
0 |
2 (<1%) |
2 (<1%) |
| Other |
38 (9%) |
42 (11%) |
80 (10%) |
| Weight (kg): |
50.4 ± 15.7
(n=400) |
50.6 ± 15.3
(n=398) |
50.5 ± 15.5
(n=798) |
| Height (cm): |
153.3 ± 11.7
(n=400) |
152.9 ± 11.3
(n=398) |
153.1 ± 11.5
(n=798) |
| Body Mass Index: |
21.1 ± 4.7
(n=400) |
21.4 ± 5.0
(n=398) |
21.2 ± 4.8
(n=798) |
|
